These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9696194)

  • 1. G-CSF association with prolonged survival in HIV-infected patients with disseminated Mycobacterium avium complex infection.
    Keiser P; Rademacher S; Smith J; Skiest D
    Int J STD AIDS; 1998 Jul; 9(7):394-9. PubMed ID: 9696194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection.
    Keiser P; Nassar N; Skiest D; Rademacher S; Smith JW
    Int J STD AIDS; 1999 Dec; 10(12):791-4. PubMed ID: 10639059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
    Burman WJ; Reves RR; Rietmeijer CA; Cohn DL
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):163-9. PubMed ID: 9441082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
    Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
    AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals.
    Shafran SD
    Int J Infect Dis; 1998; 3(1):39-47. PubMed ID: 9831675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex.
    Ives DV; Davis RB; Currier JS
    AIDS; 1995 Mar; 9(3):261-6. PubMed ID: 7755914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
    Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC
    AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of multiple drug therapy regimens for HIV-related disseminated Mycobacterium avium complex disease.
    Kissinger P; Clark R; Morse A; Brandon W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):133-7. PubMed ID: 7749789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.
    Horsburgh CR; Havlik JA; Ellis DA; Kennedy E; Fann SA; Dubois RE; Thompson SE
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):557-9. PubMed ID: 1892294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
    Karakousis PC; Moore RD; Chaisson RE
    Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
    May T; Brel F; Beuscart C; Vincent V; Perronne C; Doco-Lecompte T; Saint-Marc T; Dautzenberg B; Grosset J
    Clin Infect Dis; 1997 Sep; 25(3):621-9. PubMed ID: 9314450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients.
    Keiser P; Rademacher S; Smith JW; Skiest D; Vadde V
    Am J Med; 1998 Jan; 104(1):48-55. PubMed ID: 9528719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.